Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 3.85
(-4.7%)
CNY 3.85
(-4.7%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -484.41 Million CNY | -235.33% |
| 2022 | 357.96 Million CNY | 28.81% |
| 2021 | 277.9 Million CNY | -33.64% |
| 2020 | 418.79 Million CNY | -15.1% |
| 2019 | 493.25 Million CNY | -25.74% |
| 2018 | 664.25 Million CNY | 6.04% |
| 2017 | 626.41 Million CNY | 9.92% |
| 2016 | 569.9 Million CNY | 21.09% |
| 2015 | 470.63 Million CNY | 26.68% |
| 2014 | 371.52 Million CNY | 16.14% |
| 2013 | 319.89 Million CNY | 26.08% |
| 2012 | 253.73 Million CNY | 6.47% |
| 2011 | 238.32 Million CNY | 30.07% |
| 2010 | 183.23 Million CNY | 40.08% |
| 2009 | 130.8 Million CNY | 31.59% |
| 2008 | 99.4 Million CNY | 15.06% |
| 2007 | 86.39 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -5.44 Million CNY | -107.54% |
| 2024 Q2 | 72.24 Million CNY | 11.48% |
| 2024 Q1 | 64.8 Million CNY | 109.92% |
| 2023 Q4 | -653.05 Million CNY | -2442.87% |
| 2023 FY | -484.41 Million CNY | -235.33% |
| 2023 Q1 | 125.84 Million CNY | 362.92% |
| 2023 Q2 | 14.91 Million CNY | -88.15% |
| 2023 Q3 | 27.87 Million CNY | 86.87% |
| 2022 Q4 | 27.18 Million CNY | 37.63% |
| 2022 Q3 | 19.75 Million CNY | -61.61% |
| 2022 Q2 | 51.44 Million CNY | -68.49% |
| 2022 Q1 | 163.27 Million CNY | 415.26% |
| 2022 FY | 357.96 Million CNY | 28.81% |
| 2021 Q2 | 33.84 Million CNY | -53.64% |
| 2021 Q3 | 42.85 Million CNY | 26.6% |
| 2021 Q1 | 73 Million CNY | 565.18% |
| 2021 FY | 277.9 Million CNY | -33.64% |
| 2021 Q4 | 31.68 Million CNY | -26.05% |
| 2020 Q3 | 57.75 Million CNY | 30.06% |
| 2020 FY | 418.79 Million CNY | -15.1% |
| 2020 Q1 | 110.18 Million CNY | 580.83% |
| 2020 Q2 | 44.4 Million CNY | -59.7% |
| 2020 Q4 | -15.69 Million CNY | -127.17% |
| 2019 Q2 | 97.67 Million CNY | -46.27% |
| 2019 FY | 493.25 Million CNY | -25.74% |
| 2019 Q3 | 101.27 Million CNY | 3.69% |
| 2019 Q1 | 181.78 Million CNY | -11.33% |
| 2019 Q4 | -22.91 Million CNY | -122.63% |
| 2018 Q2 | 146.78 Million CNY | -17.33% |
| 2018 Q4 | 205.01 Million CNY | 51.96% |
| 2018 Q1 | 177.54 Million CNY | -19.31% |
| 2018 FY | 664.25 Million CNY | 6.04% |
| 2018 Q3 | 134.91 Million CNY | -8.09% |
| 2017 Q4 | 220.03 Million CNY | 89.8% |
| 2017 FY | 626.41 Million CNY | 9.92% |
| 2017 Q1 | 160.39 Million CNY | -18.67% |
| 2017 Q2 | 130.05 Million CNY | -18.91% |
| 2017 Q3 | 115.92 Million CNY | -10.86% |
| 2016 Q1 | 131.39 Million CNY | -34.16% |
| 2016 Q3 | 120.95 Million CNY | 0.53% |
| 2016 FY | 569.9 Million CNY | 21.09% |
| 2016 Q2 | 120.32 Million CNY | -8.43% |
| 2016 Q4 | 197.22 Million CNY | 63.05% |
| 2015 Q4 | 199.57 Million CNY | 199.34% |
| 2015 FY | 470.63 Million CNY | 26.68% |
| 2015 Q3 | 66.67 Million CNY | -27.61% |
| 2015 Q2 | 92.09 Million CNY | -17.99% |
| 2015 Q1 | 112.29 Million CNY | -30.05% |
| 2014 Q4 | 160.53 Million CNY | 215.6% |
| 2014 Q2 | 70.67 Million CNY | -21.0% |
| 2014 Q3 | 50.86 Million CNY | -28.02% |
| 2014 FY | 371.52 Million CNY | 16.14% |
| 2014 Q1 | 89.45 Million CNY | -31.97% |
| 2013 Q4 | 131.48 Million CNY | 182.29% |
| 2013 FY | 319.89 Million CNY | 26.08% |
| 2013 Q3 | 46.57 Million CNY | -26.75% |
| 2013 Q1 | 78.24 Million CNY | -9.16% |
| 2013 Q2 | 63.58 Million CNY | -18.74% |
| 2012 Q2 | 41.44 Million CNY | -43.37% |
| 2012 FY | 253.73 Million CNY | 6.47% |
| 2012 Q1 | 73.18 Million CNY | -18.62% |
| 2012 Q3 | 52.97 Million CNY | 27.81% |
| 2012 Q4 | 86.14 Million CNY | 62.62% |
| 2011 FY | 238.32 Million CNY | 30.07% |
| 2011 Q4 | 89.92 Million CNY | 99.74% |
| 2011 Q1 | 59.82 Million CNY | -36.19% |
| 2011 Q2 | 43.55 Million CNY | -27.2% |
| 2011 Q3 | 45.02 Million CNY | 3.38% |
| 2010 Q4 | 93.75 Million CNY | 129.53% |
| 2010 Q2 | 27.77 Million CNY | 33.22% |
| 2010 FY | 183.23 Million CNY | 40.08% |
| 2010 Q1 | 20.85 Million CNY | -71.27% |
| 2010 Q3 | 40.84 Million CNY | 47.06% |
| 2009 Q3 | 19.99 Million CNY | -32.18% |
| 2009 FY | 130.8 Million CNY | 31.59% |
| 2009 Q4 | 72.58 Million CNY | 263.01% |
| 2009 Q1 | 8.74 Million CNY | 0.0% |
| 2009 Q2 | 29.48 Million CNY | 237.09% |
| 2008 FY | 99.4 Million CNY | 15.06% |
| 2007 FY | 86.39 Million CNY | 0.0% |